Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 7 studies | 24% ± 5% | |
non-classical monocyte | 4 studies | 30% ± 6% |
Insufficient scRNA-seq data for expression of SCO2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 85.39 | 1442 / 1445 | 68% | 2.81 | 125 / 183 |
uterus | 98% | 51.81 | 166 / 170 | 49% | 2.11 | 225 / 459 |
bladder | 100% | 50.90 | 21 / 21 | 40% | 1.40 | 202 / 504 |
stomach | 99% | 51.78 | 354 / 359 | 40% | 1.16 | 113 / 286 |
intestine | 100% | 91.50 | 964 / 966 | 38% | 1.47 | 199 / 527 |
lung | 100% | 142.14 | 578 / 578 | 37% | 0.91 | 422 / 1155 |
kidney | 99% | 98.53 | 88 / 89 | 26% | 0.54 | 238 / 901 |
pancreas | 90% | 30.67 | 296 / 328 | 30% | 0.56 | 54 / 178 |
skin | 100% | 91.19 | 1806 / 1809 | 21% | 0.37 | 97 / 472 |
breast | 100% | 78.44 | 459 / 459 | 17% | 0.36 | 186 / 1118 |
liver | 100% | 86.11 | 226 / 226 | 11% | 0.18 | 44 / 406 |
thymus | 98% | 59.51 | 640 / 653 | 12% | 0.29 | 70 / 605 |
prostate | 99% | 55.04 | 242 / 245 | 4% | 0.06 | 22 / 502 |
adrenal gland | 100% | 90.67 | 258 / 258 | 2% | 0.03 | 5 / 230 |
spleen | 100% | 112.11 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 100.56 | 1200 / 1204 | 0% | 0 | 0 / 0 |
muscle | 98% | 48.36 | 790 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 61.04 | 840 / 861 | 0% | 0 | 0 / 0 |
ovary | 67% | 19.31 | 120 / 180 | 31% | 0.53 | 132 / 430 |
peripheral blood | 97% | 120.53 | 903 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 95% | 47.37 | 1270 / 1335 | 0% | 0 | 0 / 0 |
brain | 89% | 39.77 | 2348 / 2642 | 6% | 0.11 | 41 / 705 |
tonsil | 0% | 0 | 0 / 0 | 64% | 3.25 | 29 / 45 |
lymph node | 0% | 0 | 0 / 0 | 52% | 1.25 | 15 / 29 |
eye | 0% | 0 | 0 / 0 | 9% | 0.12 | 7 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0003012 | Biological process | muscle system process |
GO_0033617 | Biological process | mitochondrial cytochrome c oxidase assembly |
GO_0006878 | Biological process | intracellular copper ion homeostasis |
GO_0014823 | Biological process | response to activity |
GO_0001701 | Biological process | in utero embryonic development |
GO_0022904 | Biological process | respiratory electron transport chain |
GO_0001654 | Biological process | eye development |
GO_0030016 | Cellular component | myofibril |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0015035 | Molecular function | protein-disulfide reductase activity |
GO_0005507 | Molecular function | copper ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0016531 | Molecular function | copper chaperone activity |
Gene name | SCO2 |
Protein name | Protein SCO2 homolog, mitochondrial Synthesis of cytochrome C oxidase 2 |
Synonyms | |
Description | FUNCTION: Copper metallochaperone essential for the synthesis and maturation of cytochrome c oxidase subunit II (MT-CO2/COX2). Involved in transporting copper to the Cu(A) site on MT-CO2/COX2 . Also acts as a thiol-disulfide oxidoreductase to regulate the redox state of the cysteines in SCO1 during maturation of MT-CO2/COX2 . . |
Accessions | ENST00000395693.8 ENST00000638598.2 ENST00000535425.5 O43819 ENST00000543927.6 ENST00000252785.3 A0A1W2PQK0 |